patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: In the News - sweet

''Pluristem has a market capitalization of $112 million, a steal for what investors are getting. Not just the huge PAD market, but many other important disease targets that number in the billions of dollars. I stand by my belief that Pluristem is in for a move to $8 over the next few months and could increase in value by 5 to7 times within one year.''

http://seekingalpha.com/article/729141-pluristem-therapeutics-answer-to-big-pharma-s-question-what-do-we-do-now?source=yahoo

e

Share
New Message
Please login to post a reply